Although incidental gallbladder cancer (IGBC) diagnosed after laparoscopic cholecystectomy (LC) is not rare, its incidence, management, and prognosis are still unclear and controversial.
Laparoscopic cholecystectomy (LC) has become the gold standard surgical procedure for cholecystectomy because of its convenience and safety. For patients diagnosed with benign disease before and during LC, postoperative pathological examination may still suggest IGBC.
However, the exact incidence, proper management, and possible prognosis of IGBC after LC remain unclear and controversial. The present study aimed to clarify the incidence, management, and prognosis of IGBC after LC to ultimately increase its understanding and improve patient outcomes. Toward this goal, we retrospectively reported 26 patients with IGBC after LC treated at our facility. We analyzed their clinical features and explored the management methods and prognosis. Differences between patients with different prognoses were compared and analyzed. We also compared the differences between patients with IGBC after and during LC.
METHODS

Patients
The medical records of patients who underwent LC at our hospital between January 2001 and December 2018 were reviewed retrospectively. The inclusion criteria were: (1) benign disease was diagnosed via ultrasonography or computed tomography (CT) preoperatively,
(2) the patient underwent LC at our facility, (3) IGBC was confirmed via postoperative pathology, and (4) the patient either underwent radical reoperation or consented to close follow-up at our hospital.
Patients were excluded if they were preoperatively or intraoperatively suspected of having GBC. Clinical data were collected from both outpatient and inpatient medical records by two independent doctors. A retrospective database containing demographic features, laboratory and imaging tests, underlying diseases, operation information, pathological results, and prognoses was constructed and analyzed.
Treatment and follow-up
All patients underwent ultrasonography or CT before surgery. No antibiotic or laxative was administered. Surgery was conducted under general anesthesia in all cases, and LC was executed using the threetrocar technique. An endopouch was routinely used when retrieving the gallbladder to protect portsite. Intraoperative frozen section was performed if suspicious lesion was found via macroscopic inspection and palpation of the gallbladder. All specimens were examined by two to three different pathologists.
For patients with IGBC after LC, radical reoperation was recommended for T1b and more advanced lesions except those with serious underlying disease. Both the benefits and risks of reoperation and close follow-up were explained to patients with T1a stage (ie, the tumor invading only the lamina propria), and the management strategy was decided according to the patients' preference. For patients who consented to radical reoperation, the revisional procedure included wedge resection of the gallbladder bed, regional lymph node dissection of the hepatoduodenal ligament, and lymph node dissection around the pancreatic head and duodenum. Complications were defined as any abnormal event recorded within 30 days after surgery and classified according to the Clavien-Dindo classification of surgical complications. 12 Outpatient interviews and telephone calls were used for follow-up. All patients were followed up every 3 months during the first postoperative year, and every 6 months thereafter. Reexamination included ultrasonography, CT, and blood test. was considered statistically significant.
Statistical analysis
Ethics
The present study was approved by the Peking Union Medical College Hospital Institutional Review Board (S-K951). All patients or their legal guardian provided written informed consent for the surgical procedures performed. The requirement of informed consent for publication of data was waived owing to the retrospective nature of the study.
RESULTS
Patient characteristics
Between January 2001 and December 2018, a total of 11 589 patients underwent LC at our hospital. Of these, 26 patients (0.2%) with IGBC after LC were included in this study ( Figure 1 ). During the same period, a total of 480 patients with GBC were admitted to our hospital, and the 26 patients with IGBC after LC accounted for 5.4%. The demographic data and preoperative symptoms of the enrolled patients are presented in Table 1 . The most common symptom was abdominal pain, occurring in 16 patients (61.5%). The age and sex distribution are presented in Figure 2 . IGBC was more common among women and older patients. 
Preoperative findings
Surgical outcomes
All LC procedures were successfully completed without conversion to laparotomy. Postoperative complications occurred in two patients. One patient had urinary retention, which was managed using catheterization. The other patient had fever and was treated with antipyretics. These complications were classified as grade I following the Clavien-Dindo classification of surgical complications.
All patients were diagnosed with IGBC via postoperative pathology within a mean of 6. 
Risk factors of poor prognosis
To analyze potential risk factors associated with poor prognosis, the patients were divided into two groups for analysis: the survival group and the nonsurvivor group. The former included patients who were still alive at the last follow-up (n = 12). The latter included patients (Table 4 ).
However, no variable proved to be independently associated with poor prognosis.
The cumulative overall survival rate for IGBC patients with any T-stage was shown in a Kaplan-Meier curve ( Figure 3A) . The 1-, 3-, and 5-year cumulative overall survival rates of the entire cohort were 79.8, 49.0, and 40.8%, respectively. The mean survival period was 50.5 months. The cumulative overall survival rates calculated separately according to T-stage are shown in Figure 3B . with T1b and T2 disease was too small and the curves in Figure 3B overlap, T1b, T2, and T3 stages were combined into one group and compared with T1a stage ( Figure 3C ). IGBC patients with T1a stage had significantly longer survival than those with T1b or more advanced stages (96.1 vs 32.6 months, P = .006). Table 5 . Patients with IGBC discovered intraoperatively were more likely to accept radical operation than those with IGBC discovered postoperatively (32.5, 13/40 vs 11.5, 3/26); however, the difference was not statistically significant (P = .052).
Differences between IGBC after and during LC
DISCUSSION
GBC is an aggressive malignancy with poor prognosis. Due to the particularity of anatomic location and atypical symptoms, both the early diagnosis rate and preoperative diagnosis rate of GBC are not high, and IGBC is not uncommon. In the present study, the incidence of IGBC after LC is 0.2%, and that accounts for 5.4% of all GBC cases. These rates are lower than those in the literature [8] [9] [10] and may be because we gave profound importance to preoperative imaging examination, intraoperative palpation, and frozen pathology when necessary. Compared with intraoperative IGBC, postoperative IGBC often causes greater psychological and physical trauma to patients because it involves reoperation.
Current guidelines recommend reoperation for IGBC after LC for T1b, T2, and T3 lesions. 13 Glauser et al suggested extended resection of the regional lymph nodes and gallbladder bed for IGBC patients after LC with T2 and T3 disease. 15 Meanwhile, Tian et al recommended radical resection for IGBC patients with T1b or more advanced stage. 16 In the present study, radical reoperation was recommended for T1b or more advanced lesions, unless contraindicated by poor performance status or advanced underlying disease. However, only 3 of 16 patients consented to reoperations. The patients refused reoperation primarily due to advanced age (9/13, 69.2%), and this may be related to the old mean age in this study (66.4 ± 12.5 years).
In the analysis of possible risk factors associated with poor prognosis, old age and advanced T-stage were found significant in univariate analysis. Older patients generally have worse health conditions, recover more slowly after surgery, and are more likely to choose a more conservative treatment. However, neither proved to be independently associated with poor prognosis in multivariate analysis, and this may be related to the limited number of patients in this study. Nevertheless, Kaplan-Meier analysis with log-rank test to calculate the mean expected survival period of IGBC patients according to T-stage showed significant differences. The T-stage is crucial in the prognosis of GBC as it directly indicates tumor prognosis. 2, 6, 17, 18 Patients with T1a lesion survived significantly longer than those with T1b or more advanced lesions. Several previous studies reported that patients with T1a IGBC could achieve long-term survival via simple cholecystectomy. 1, [19] [20] [21] Similarly, in the present study, all the 10 T1a patients underwent LC only, and 9 of them (90.0%) survived without recurrence.
In the present study, the mean survival period of all IGBC patients was 50.5 months, and the 1-, 3-, and 5-year cumulative overall survival rates were 79.8, 49.0, and 40.8%, respectively, and these rates are markedly better than those reported for GBC in the literature 6, 7, [22] [23] [24] [25] As mentioned above, the T-stage is directly related to the prognosis of A major feature of this study is that the majority of patients (23/26, 88.5%) did not undergo reoperation. Therefore, the prognosis of patients in the present study can basically reflect the natural course of IGBC. Of the 23 patients who did not undergo reoperation, 9 of 10 (90.0%) patients with T1a survived without recurrence, one of three (33.3%) for T1b, zero of three (0.0%) for T2, and one of seven (14.3%) for T3. This result also proves that simple cholecystectomy is feasible only in T1a lesion.
There are some limitations to this study. First, the number of patients, registration information, and variables assessed are limited by its retrospective design. Second, due to the limited patient volume, IGBC with different T-stages cannot be discussed and compared separately. Third, the small number of patients who underwent reoperation did not allow for an evaluation of the prognostic impact of this factor. Multicenter, prospective, and controlled clinical trials are needed to confirm our findings.
In conclusion, IGBC after LC has an incidence of 0.2%, and this accounts for 5.4% of all GBC cases. IGBC was more common in older and female. The 1-, 3-, and 5-year cumulative overall survival rates of IGBC after LC were 79.8, 49.0, and 40.8%, respectively. The mean survival period was 50.5 months. IGBC patients with T1a stage had significantly longer survival than those with T1b or more advanced stages (96.1 vs 32.6 months, P = .006). Simple cholecystectomy is probably feasible only in T1a lesion.
